145 related articles for article (PubMed ID: 15809017)
1. Growth hormone responses to varying doses of oral arginine.
Collier SR; Casey DP; Kanaley JA
Growth Horm IGF Res; 2005 Apr; 15(2):136-9. PubMed ID: 15809017
[TBL] [Abstract][Full Text] [Related]
2. Oral arginine attenuates the growth hormone response to resistance exercise.
Collier SR; Collins E; Kanaley JA
J Appl Physiol (1985); 2006 Sep; 101(3):848-52. PubMed ID: 16741262
[TBL] [Abstract][Full Text] [Related]
3. The effects of dietary protein on the somatotropic axis: a comparison of soy, gelatin, alpha-lactalbumin and milk.
van Vught AJ; Nieuwenhuizen AG; Veldhorst MA; Brummer RJ; Westerterp-Plantenga MS
Eur J Clin Nutr; 2010 May; 64(5):441-6. PubMed ID: 20216569
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, arginine and exercise.
Kanaley JA
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):50-4. PubMed ID: 18090659
[TBL] [Abstract][Full Text] [Related]
5. IGF-I does not affect the net increase in GH release in response to arginine.
Nass R; Pezzoli SS; Chapman IM; Patrie J; Hintz RL; Hartman ML; Thorner MO
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E702-10. PubMed ID: 12217887
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.
Koutkia P; Eaton K; You SM; Breu J; Grinspoon S
AIDS; 2006 Apr; 20(6):855-62. PubMed ID: 16549969
[TBL] [Abstract][Full Text] [Related]
7. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
8. The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.
Blazejewski S; Georges A; Forest K; Corcuff JB; Abouelfath A; Girodet PO; Kamagate M; Jacquet A; Pillet O; Bordenave L; Moore N
Fundam Clin Pharmacol; 2009 Jun; 23(3):339-44. PubMed ID: 19527301
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
Díez JJ; Grande C; Méndez J; González-Gancedo P; Iglesias P
Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
[TBL] [Abstract][Full Text] [Related]
10. Oral L-arginine before resistance exercise blunts growth hormone in strength trained males.
Forbes SC; Harber V; Bell GJ
Int J Sport Nutr Exerc Metab; 2014 Apr; 24(2):236-44. PubMed ID: 24225560
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of growth hormone release in man by the potent D2-dopamine agonist CV 205-502: comparison of responses to intravenous and oral administration.
Miell JP; Pralong FP; Corder R; Gaillard RC
J Clin Endocrinol Metab; 1990 Dec; 71(6):1519-24. PubMed ID: 1977760
[TBL] [Abstract][Full Text] [Related]
12. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
[TBL] [Abstract][Full Text] [Related]
13. The acute effects of a low and high dose of oral L-arginine supplementation in young active males at rest.
Forbes SC; Bell GJ
Appl Physiol Nutr Metab; 2011 Jun; 36(3):405-11. PubMed ID: 21574873
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent response of plasma ghrelin and growth hormone concentrations to bovine ghrelin in Holstein heifers.
ThidarMyint H; Yoshida H; Ito T; Kuwayama H
J Endocrinol; 2006 Jun; 189(3):655-64. PubMed ID: 16731795
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral ingestion of amino acids and proteins on the somatotropic axis.
van Vught AJ; Nieuwenhuizen AG; Brummer RJ; Westerterp-Plantenga MS
J Clin Endocrinol Metab; 2008 Feb; 93(2):584-90. PubMed ID: 18029456
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
Ham JN; Ginsberg JP; Hendell CD; Moshang T
Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
[TBL] [Abstract][Full Text] [Related]
18. [Oral administration effects, with different doses, of arginine aspartate and arginine chlorhydrate upon growth hormone and free fatty acids plasmatic rates in normal fasting children (author's transl)].
Elsair J; Poey J; Rochiccioli P; Denine R; Merad R; Benouniche N
Pathol Biol (Paris); 1980 Dec; 28(10):639-44. PubMed ID: 7007997
[TBL] [Abstract][Full Text] [Related]
19. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
